Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Thor Trovik"'
Autor:
Jan Ravkilde, Thor Trovik, Rikard Linder, Keith G. Oldroyd, Juha Hartikainen, Gintaras Kalinauskas, Niels Ramsing Holm, Leif Thuesen, Evald Høj Christiansen, Thomas Kellerth, Michael Maeng, Peteris Stradins, Hannu Romppanen, Mark S. Spence, Terje K. Steigen, Ole Fröbert, Markku O. Pentikäinen, Colm G. Hanratty, Matti Niemelä, Vesa Anttila, Indulis Kumsars, Per Hostrup Nielsen, Ian B. A. Menown, Uday Trivedi, Olli A. Kajander, Erlend Eriksen, Jens Flensted Lassen, Mitchell Lindsay, Timo H. Mäkikallio, Adrian P. Banning, Kari Kervinen, Lisette Okkels Jensen, Sulev Margus, Petter C Endresen, Azfar Zaman, Simon J Walsh, Markku Eskola, Matthias Corbascio, Henrik Toft Sørensen, Jamen Cotton, Andrejs Erglis, Alastair N J Graham, Anders Hervold, David Hildick-Smith, Geoff Berg
Publikováno v:
Mäkikallio, T, Holm, N R, Lindsay, M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Eskola, M, Romppanen, H, Kellerth, T, Ravkilde, J, Jensen, L O, Kalinauskas, G, Linder, R B A, Pentikainen, M, Hervold, A, Banning, A, Zaman, A, Cotton, J, Eriksen, E, Margus, S, Sørensen, H T, Nielsen, P H, Niemelä, M, Kervinen, K, Lassen, J F, Maeng, M, Oldroyd, K, Berg, G, Walsh, S J, Hanratty, C G, Kumsars, I, Stradins, P, Steigen, T K, Fröbert, O, Graham, A N J, Endresen, P C, Kajander, O, Trivedi, U, Hartikainen, J, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE study investigators 2016, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE) : a prospective, randomised, open-label, non-inferiority trial ', The Lancet, vol. 388, no. 10061, pp. 2743-2752 . https://doi.org/10.1016/S0140-6736(16)32052-9
Mäkikallio, T, Holm, N R, Lindsay, M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Eskola, M, Romppanen, H, Kellerth, T, Ravkilde, J, Jensen, L O, Kalinauskas, G, Linder, R B A, Pentikainen, M, Hervold, A, Banning, A, Zaman, A, Cotton, J, Eriksen, E, Margus, S, Sørensen, H T, Nielsen, P H, Niemelä, M, Kervinen, K, Lassen, J F, Maeng, M, Oldroyd, K, Berg, G, Walsh, S J, Hanratty, C G, Kumsars, I, Stradins, P, Steigen, T K, Fröbert, O, Graham, A N J, Endresen, P C, Corbascio, M, Kajander, O, Trivedi, U, Hartikainen, J, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE study investigators 2016, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE) : a prospective, randomised, open-label, non-inferiority trial ', Lancet, vol. 388, no. 10061, pp. 2743–2752 . https://doi.org/10.1016/S0140-6736(16)32052-9
Berg, G & for the NOBLE study investigators 2016, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE) : a prospective, randomised, open-label, non-inferiority trial ', Lancet Oncology, vol. 388, no. 10061, pp. 2743-2752 . https://doi.org/10.1016/s0140-6736(16)32052-9
Mäkikallio, T, Holm, N R, Lindsay, M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Eskola, M, Romppanen, H, Kellerth, T, Ravkilde, J, Jensen, L O, Kalinauskas, G, Linder, R B A, Pentikainen, M, Hervold, A, Banning, A, Zaman, A, Cotton, J, Eriksen, E, Margus, S, Sørensen, H T, Nielsen, P H, Niemelä, M, Kervinen, K, Lassen, J F, Maeng, M, Oldroyd, K, Berg, G, Walsh, S J, Hanratty, C G, Kumsars, I, Stradins, P, Steigen, T K, Fröbert, O, Graham, A N J, Endresen, P C, Corbascio, M, Kajander, O, Trivedi, U, Hartikainen, J, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE study investigators 2016, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE) : a prospective, randomised, open-label, non-inferiority trial ', Lancet, vol. 388, no. 10061, pp. 2743–2752 . https://doi.org/10.1016/S0140-6736(16)32052-9
Berg, G & for the NOBLE study investigators 2016, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE) : a prospective, randomised, open-label, non-inferiority trial ', Lancet Oncology, vol. 388, no. 10061, pp. 2743-2752 . https://doi.org/10.1016/s0140-6736(16)32052-9
BACKGROUND: Coronary artery bypass grafting (CABG) is the standard treatment for revascularisation in patients with left main coronary artery disease, but use of percutaneous coronary intervention (PCI) for this indication is increasing. We aimed to